Dynamic stromal cellular reaction throughout human colorectal adenoma-carcinoma sequence: A role of TH17/IL-17A

被引:19
作者
Cui, Guanglin [1 ,2 ]
Li, Zhenfeng [1 ]
Florholmen, Jon [3 ]
Goll, Rasmus [3 ]
机构
[1] Zhengzhou Univ, Res Grp Gastrointestinal Dis, Affiliated Hosp 2, Zhengzhou, Henan, Peoples R China
[2] Nord Univ Levanger, Fac Heath Sci, Campus Levanger, Levanger, Norway
[3] Arctic Univ Norway, Res Grp Gastroenterol Nutr, Tromso, Norway
基金
中国国家自然科学基金;
关键词
Stroma; TH17; Cytokine; Carcinogenesis; Colorectum; MESENCHYMAL STEM-CELLS; CANCER-ASSOCIATED FIBROBLASTS; TUMOR MICROENVIRONMENT; INCREASED EXPRESSION; IL-17A; CD146; RECEPTOR; DIFFERENTIATION; INTERLEUKIN-17A; TRANSITION;
D O I
10.1016/j.biopha.2021.111761
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Background: Accumulating data suggest that the tumour stroma rapidly undergoes dynamic mechanical and cellular changes by which creates a supportive milieu to promote disease progression and metastasis. Cytokines are reported to play a key role in the modulation of tumour stromal response. Methods: The activation of TH17/interleukin (IL)-17A network in association with tumour stromal proliferative and cellular response in samples from 50 patients with colorectal adenoma, 45 with colorectal cancer (CRCs) were elucidated with quantitative real-time PCR (q-PCR), immunohistochemistry and double immunofluorescence. Results: q-PCR results showed that retinoic acid-receptor-related orphan receptor-C, a critical transcriptional factor for TH17 cell differentiation, was significantly increased at the adenoma stage and slightly decreased at the CRC stage, but was still higher than that at normal controls. The level of TH17 signature cytokine IL-17A was shown in an increasing gradient throughout the adenoma-carcinoma sequence. Immunohistochemistry revealed an activated proliferative rate evaluated by Ki67 and population expansion of myofibroblasts in the adenoma/ CRC stroma. Notably, densities of IL-17A-expressing cells were associated with populations of Ki67-positive cells and myofibroblasts in the adenoma/CRC stroma. Finally, CD146-positive stromal cells are an important participator for stroma remodelling, double immunofluorescence image demonstrated that IL-17 receptor C, one of the key elements for IL-17 receptor complex, was highly expressed in CD146-positive adenoma/CRC stromal cells. Conclusions: An activated TH17/IL-17A network in the tumour microenvironment is significantly associated with dynamic stromal cellular response throughout the adenoma-carcinoma sequence, which might provide a supportive environment for the initiation and progression of CRC.
引用
收藏
页数:9
相关论文
共 77 条
[31]
Interleukin-17A: A T-cell-derived growth factor for murine and human mesenchymal stem cells [J].
Huang, Weitao ;
La Russa, Vincent ;
Alzoubi, Azam ;
Schwarzenberger, Paul .
STEM CELLS, 2006, 24 (06) :1512-1518
[32]
Role of IL-17A in the development of colitis-associated cancer [J].
Hyun, Yil Sik ;
Han, Dong Soo ;
Lee, A. Reum ;
Eun, Chang Soo ;
Youn, Jeehee ;
Kim, Ho-Youn .
CARCINOGENESIS, 2012, 33 (04) :931-936
[33]
Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer? [J].
Ibrahim, Sajida ;
Girault, Alban ;
Ohresser, Marc ;
Lereclus, Emilie ;
Paintaud, Gilles ;
Lecomte, Thierry ;
Raoul, William .
CLINICAL COLORECTAL CANCER, 2018, 17 (01) :E109-E113
[34]
Transcriptional regulation of Th17 cell differentiation [J].
Ivanov, Ivaylo I. ;
Zhou, Liang ;
Littman, Dan R. .
SEMINARS IN IMMUNOLOGY, 2007, 19 (06) :409-417
[35]
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells [J].
Ivanov, Ivaylo I. ;
McKenzie, Brent S. ;
Zhou, Liang ;
Tadokoro, Carlos E. ;
Lepelley, Alice ;
Lafaille, Juan J. ;
Cua, Daniel J. ;
Littman, Dan R. .
CELL, 2006, 126 (06) :1121-1133
[36]
CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis [J].
Jiang, Tianxia ;
Zhuang, Jie ;
Duan, Hongxia ;
Luo, Yongting ;
Zeng, Qiqun ;
Fan, Kelong ;
Yan, Huiwen ;
Lu, Di ;
Ye, Zhongde ;
Hao, Junfeng ;
Feng, Jing ;
Yang, Dongling ;
Yan, Xiyun .
BLOOD, 2012, 120 (11) :2330-2339
[37]
IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis [J].
Kurte, Monica ;
Luz-Crawford, Patricia ;
Vega-Letter, Ana Mara ;
Contreras, Rafael A. ;
Tejedor, Gautier ;
Elizondo-Vega, Roberto ;
Martinez-Viola, Luna ;
Fernandez-O'Ryan, Catalina ;
Figueroa, Fernando E. ;
Jorgensen, Christian ;
Djouad, Farida ;
Carrion, Flavio .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[38]
Increased TGF-beta1 protein expression in patients with advanced colorectal cancer [J].
Langenskiod, Marcus ;
Holmdahl, Lena ;
Falk, Peter ;
Angenete, Eva ;
Ivarsson, Marie-Louise .
JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (05) :409-415
[39]
Recent discoveries concerning the tumor - mesenchymal stem cell interactions [J].
Lazennec, Gwendal ;
Lam, Paula Y. P. .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2016, 1866 (02) :290-299
[40]
The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer [J].
Le Corre, Delphine ;
Ghazi, Alexandre ;
Balogoun, Ralyath ;
Pilati, Camilla ;
Aparicio, Thomas ;
Martin-Lanneree, Severine ;
Marisa, Laetitia ;
Djouadi, Fatima ;
Poindessous, Virginie ;
Crozet, Carole ;
Emile, Jean-Francois ;
Mulot, Claire ;
Le Malicot, Karine ;
Boige, Valerie ;
Blons, Helene ;
de Reynies, Aurelien ;
Taieb, Julien ;
Ghiringhelli, Francois ;
Bennouna, Jaafar ;
Launay, Jean-Marie ;
Laurent-Puig, Pierre ;
Mouillet-Richard, Sophie .
EBIOMEDICINE, 2019, 46 :94-104